Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kasr El Aini Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Misoprostol is a synthetic analogue of the naturally occurring prostaglandin E1. It was initially marketed for the treatment of peptic ulcers due to its mucosal protective and anti-secretory properties, but has commonly been used for the induction of abortion and labour .
Although initially having been established for oral use, misoprostol tablets are commonly used as vaginal suppositories for the previously purposes. Water or saline are frequently used in common practice to moisten the tablets prior to their administration, however, according to the pharmacokinetics of the drug, it should liquefy better in an acidic medium
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| misoprostol in neutral media | Placebo Comparator | Intervention : misoprostol in a neutral media will be given to women to induce labour |
|
| Misoprostol in acidic media | Active Comparator | Intervention : misoprostol in acidic media will be given to induce labour |
|
| Misoprostol in alkaline media | Sham Comparator | Intervention : misoprostol in alkaline media will be given to induce labour |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| misoprostol in a neutral media | Drug | giving misoprostol in a neutral media |
|
| Measure | Description | Time Frame |
|---|---|---|
| The number of women who will start lactive phase of labour after treatment | the number of women in a group who will enter in active labour faster than other groups | within 24 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Full term pregnant women
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mahmoud Alalfy | Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Algazeerah and Kasralainy hospital | Recruiting | Giza | Egypt |
Not provided
| ID | Term |
|---|---|
| D048949 | Labor Pain |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D016595 | Misoprostol |
| D004364 | Pharmaceutical Preparations |
| ID | Term |
|---|---|
| D011459 | Prostaglandins E, Synthetic |
| D011465 | Prostaglandins, Synthetic |
| D011453 | Prostaglandins |
| D015777 | Eicosanoids |
Not provided
Not provided
3 paralle groups
Not provided
Not provided
Not provided
| misoprostol in an acidic media | Drug | giving misoprostol in an acidic media |
|
|
| misoprostol in an alkaline media | Drug | giving misoprostol in an alkaline media |
|
|
| D005231 |
| Fatty Acids, Unsaturated |
| D005227 | Fatty Acids |
| D008055 | Lipids |
| D012898 | Autacoids |
| D018836 | Inflammation Mediators |
| D001685 | Biological Factors |